Amil, FARMASA and MB File IPOs

Brazil’s Amil Participacões has filed an IPO on the Bovespa. With more than 2.4m beneficiaries, it is the county’s largest healthcare provider, according to Brazil’s health ministry. Amil didn’t disclose a timetable or financial details of the offering, but plans to sell only common shares, indicating that it could offer shares on the Novo Mercado. Credit Suisse and UBS Pactual are the leads. Brazilian pharmaceuticals firm Laboratório Americano de Farmacoterapia (FARMASA) is also planning a Brazilian IPO. The manufacturer of the analgesic Lisador did not disclose a timetable or amount of the offering. UBS Pactual and Credit Suisse are also leading that one. Meanwhile, Brazilian real estate company MB Engenharia has also registered an IPO on the Bovespa through Unibanco and Goldman Sachs.